Skip to content
lifestyle.passionateaboutfood.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
NeOnc Technologies Holdings, Inc.
NeOnc Technologies Appoints David Choi as Chief Accounting Officer
March 13, 2026
NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET
March 4, 2026
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity
February 27, 2026
←
Previous Page
1
2